The healthcare sector is continually finding new ways to address the burdening problems associated with vitamin deficiencies. As the number of individuals suffering from vitamin deficiencies continues to grow at an exponential rate worldwide, vitamin deficiency treatments have gained a great amount of attention over the past couple of decades. Some of the major factors that are expected to influence the expansion of the vitamin deficiency treatment market during the forecast period include rising prevalence of acute and chronic disorders, surge in the number of research & development activities, and growing demand for vitamin D and vitamin B complex, owing to the health benefits.
At present, a great number of research activities are focusing on addressing health issues and risks involved with nutritional deficiencies. Vitamin D testing and treatment has witnessed considerable growth in the past few years. Guidelines pertaining to the treatment of various vitamin deficiencies continue to evolve due to research. As vitamin D deficiency continues to emerge as a global burden, apart from vitamin deficiency treatment, tackling vitamin D deficiency would require robust public health actions, including vitamin D food fortification. At the back of these factors, the global vitamin deficiency treatment market is expected to reach a value of ~US$ 9.5 Bn by the end of 2027.
Vitamin deficiencies continue to pose a major threat to the overall wellbeing of the society worldwide. Vitamin deficiencies can lead to irritability, nausea, constipation, depression, mental confusion, and muscle weakness, among others. Vitamin B12 deficiencies have increasingly been detected among athletes, individuals with high alcohol consumption, and women who consistently use birth control pills. In the current scenario, the demand for vitamin deficiency treatment is on the rise to address and predominantly incorporate a blend of vitamin B6 with synergistic B vitamins. For several decades, within clinical practices worldwide, vitamin B12 deficiencies often received a blind eye or were misdiagnosed. However, at present, trends suggest that detection, diagnosis, and vitamin deficiency treatment continue to progress at an impressive pace. Diagnosis based on low serum B12 levels and elevated biomarkers including methylmalonic acid and homocysteine continue to make headlines within the vitamin deficiency treatment market. In the current scenario, researchers are also investigating the potential benefits of deploying oral supplementation to combat the symptoms of vitamin B12 deficiency as an alternative to parental treatment.
Over the past decade and during the forecast period, researchers are increasingly exploring the potential solutions to address muscle weakness among the elderly population caused by vitamin D deficiency. The prevalence of vitamin D deficiency has witnessed unprecedented growth over the past few years, due to which the demand for supplementation of 800 IU of vitamin D is required. In most cases, vitamin D is predominantly administered in the form of cholecalciferol. The demand for cholecalciferol is expected to grow in the coming years, as it is considered to be safe for elderly people. The demand for vitamin B complex supplements is projected to remain the highest among all other types of products followed by vitamin C and vitamin D supplements.
Participants operating in the current vitamin deficiency treatment market are expected to focus on research and development activities to discover new and improved vitamin deficiency treatments. Several companies are also anticipated to eye opportunities in foreign markets, while simultaneously improving their market share in the domestic market. Product launches and expanding the product portfolio are also projected to remain some of the key strategies deployed by market players. For instance, in 2016, Abbott Laboratories expanded its product portfolio by launching two infant nutrition products, including Similac Pro-Advance and Pro-Sensitive. Several companies are also leaning toward inorganic growth strategies such as mergers & acquisitions to improve their market share and brand presence. For instance, Pfizer, Inc. acquired Emergen C in 2012, at the back of which, the sales of Pfizer saw remarkable growth.
Analysts’ Viewpoint
The global vitamin deficiency treatment market is expected to grow at a CAGR of 6.5% during the forecast period. The market growth can be primarily attributed to a range of factors, including rising prevalence of vitamin D deficiencies among the elderly population, significant development on the research front, growing emphasis on drug development, and rising awareness pertaining to vitamin deficiencies. Companies operating in the vitamin deficiency treatment market landscape should focus on mergers & acquisitions to improve their market share and overall position. Product launches, research, and expansion of the existing product portfolio are some of the other strategies that should be considered to gain ground in the current vitamin deficiency treatment market during the assessment period.
Vitamin deficiency treatment market is expected to reach a value of ~US$ 9.5 Bn by the end of 2028
Vitamin deficiency treatment market is anticipated to expand at a CAGR of 6.5% from 2020 to 2028
Vitamin deficiency treatment market is driven by rise in prevalence of several acute and chronic disorders across the world
Asia Pacific accounted for a major share of the global vitamin deficiency treatment market
Key players in the global vitamin deficiency treatment market include Koninklijke DSM N.V., Nature’s Bounty, Mallinckrodt Pharmaceuticals, and Pfizer, Inc. Mallinckrodt Pharmaceuticals
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Vitamin Deficiency Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vitamin Deficiency Treatment Market Analysis and Forecast, 2018–2028
5. Key Insights
5.1. Regulatory Scenario, by Region
5.2. Value Chain Analysis
6. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2018–2028
6.3.1. Vitamin B Complex Supplements
6.3.2. Vitamin C (Ascorbic Acid)
6.3.3. Vitamin A (Retinoids)
6.3.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)
6.3.5. Vitamin E (Tocopherol)
6.3.6. Vitamin K
6.4. Market Attractiveness, by Product Type
7. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Route of Administration, 2018–2028
7.3.1. Oral
7.3.2. Parenteral
7.4. Market Attractiveness, by Route of Administration
8. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2018–2028
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness, by Distribution Channel
9. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Vitamin Deficiency Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Product Type, 2018–2028
10.2.1. Vitamin B Complex Supplements
10.2.2. Vitamin C (Ascorbic Acid)
10.2.3. Vitamin A (Retinoids)
10.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)
10.2.5. Vitamin E (Tocopherol)
10.2.6. Vitamin K
10.3. Market Value Forecast, by Route of Administration, 2018–2028
10.3.1. Oral
10.3.2. Parenteral
10.4. Market Value Forecast, by Distribution Channel, 2018–2028
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast, by Country, 2018–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Vitamin Deficiency Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast, by Product Type, 2018–2028
11.2.1. Vitamin B Complex Supplements
11.2.2. Vitamin C (Ascorbic Acid)
11.2.3. Vitamin A (Retinoids)
11.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)
11.2.5. Vitamin E (Tocopherol)
11.2.6. Vitamin K
11.3. Market Value Forecast, by Route of Administration, 2018–2028
11.3.1. Oral
11.3.2. Parenteral
11.4. Market Value Forecast, by Distribution Channel, 2018–2028
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2018–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Vitamin Deficiency Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Product Type, 2018–2028
12.2.1. Vitamin B Complex Supplements
12.2.2. Vitamin C (Ascorbic Acid)
12.2.3. Vitamin A (Retinoids)
12.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)
12.2.5. Vitamin E (Tocopherol)
12.2.6. Vitamin K
12.3. Market Value Forecast, by Route of Administration, 2018–2028
12.3.1. Oral
12.3.2. Parenteral
12.4. Market Value Forecast, by Distribution Channel, 2018–2028
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2018–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Vitamin Deficiency Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast, by Product Type, 2018–2028
13.2.1. Vitamin B Complex Supplements
13.2.2. Vitamin C (Ascorbic Acid)
13.2.3. Vitamin A (Retinoids)
13.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)
13.2.5. Vitamin E (Tocopherol)
13.2.6. Vitamin K
13.3. Market Value Forecast, by Route of Administration, 2018–2028
13.3.1. Oral
13.3.2. Parenteral
13.4. Market Value Forecast, by Distribution Channel, 2018–2028
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2018–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Vitamin Deficiency Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Market Value Forecast, by Product Type, 2018–2028
14.2.1. Vitamin B Complex Supplements
14.2.2. Vitamin C (Ascorbic Acid)
14.2.3. Vitamin A (Retinoids)
14.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)
14.2.5. Vitamin E (Tocopherol)
14.2.6. Vitamin K
14.3. Market Value Forecast, by Route of Administration, 2018–2028
14.3.1. Oral
14.3.2. Parenteral
14.4. Market Value Forecast, by Distribution Channel, 2018–2028
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Market Value Forecast, by Country/Sub-region, 2018–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Company Profiles
15.1.1. Merck & Co., Inc.
15.1.1.1. Company Overview
15.1.1.2. Company Financials
15.1.1.3. Growth Strategies
15.1.1.4. SWOT Analysis
15.1.2. Nature’s Bounty
15.1.2.1. Company Overview
15.1.2.2. Growth Strategies
15.1.2.3. SWOT Analysis
15.1.3. Sun Pharmaceutical Industries Ltd.
15.1.3.1. Company Overview
15.1.3.2. Company Financials
15.1.3.3. Growth Strategies
15.1.3.4. SWOT Analysis
15.1.4. Pfizer, Inc.
15.1.4.1. Company Overview
15.1.4.2. Company Financials
15.1.4.3. Growth Strategies
15.1.4.4. SWOT Analysis
15.1.5. Novartis AG
15.1.5.1. Company Overview
15.1.5.2. Company Financials
15.1.5.3. Growth Strategies
15.1.5.4. SWOT Analysis
15.1.6. Cipla, Inc.
15.1.6.1. Company Overview
15.1.6.2. Company Financials
15.1.6.3. Growth Strategies
15.1.6.4. SWOT Analysis
15.1.7. DSM
15.1.7.1. Company Overview
15.1.7.2. Company Financials
15.1.7.3. Growth Strategies
15.1.7.4. SWOT Analysis
15.1.8. BASF SE
15.1.8.1. Company Overview
15.1.8.2. Company Financials
15.1.8.3. Growth Strategies
15.1.8.4. SWOT Analysis
15.1.9. Nestle
15.1.9.1. Company Overview
15.1.9.2. Company Financials
15.1.9.3. Growth Strategies
15.1.9.4. SWOT Analysis
15.1.10. GlaxoSmithKline plc
15.1.10.1. Company Overview
15.1.10.2. Company Financials
15.1.10.3. Growth Strategies
15.1.10.4. SWOT Analysis
List of Tables
Table 01: Comparison of Regulatory Requirements for Generic Drugs Dossier Submission in the U.S. and Canada
Table 02: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028
Table 03: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028
Table 04: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028
Table 05: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2028
Table 06: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028
Table 07: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028
Table 08: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028
Table 09: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2028
Table 10: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028
Table 11: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028
Table 12: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028
Table 13: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028
Table 14: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028
Table 15: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028
Table 16: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028
Table 17: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028
Table 18: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028
Table 19: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028
Table 20: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028
Table 21: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028
Table 22: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Product Type, 2018–2028
Table 23: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2028
Table 24: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2028
Table 25: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2028
List of Figures
Figure 01: Global Vitamin Deficiency Treatment Market Snapshot
Figure 02: Global Vitamin Deficiency Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2028
Figure 03: Global Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast, 2018–2028
Figure 04: Regulatory Approval Process - The U.S.
Figure 05: Regulatory Approval Process - Europe
Figure 06: Regulatory Approval Process - Japan
Figure 07: Drug Development
Figure 08: Global Vitamin Deficiency Treatment Market Value Share Analysis, by Product Type, 2019 and 2028
Figure 09: Global Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028
Figure 10: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin B Complex Supplements, 2018–2028
Figure 11: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin C (Ascorbic Acid), 2018–2028
Figure 12: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin A (Retinoids), 2018–2028
Figure 13: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D), 2018–2028
Figure 14: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin E (Tocopherol), 2018–2028
Figure 15: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitamin K, 2018–2028
Figure 16: Global Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028
Figure 17: Global Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028
Figure 18: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2018–2028
Figure 19: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral, 2018–2028
Figure 20: Global Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028
Figure 21: Global Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028
Figure 22: Global Vitamin Deficiency Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2028
Figure 23: Global Vitamin Deficiency Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2028
Figure 24: Global Vitamin Deficiency Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018–2028
Figure 25: Global Vitamin Deficiency Treatment Market Value Share Analysis, by Region, 2019 and 2028
Figure 26: Global Vitamin Deficiency Treatment Market Attractiveness Analysis, by Region, 2020–2028
Figure 27: North America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028
Figure 28: North America Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028
Figure 29: North America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028
Figure 30: North America Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028
Figure 31: North America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028
Figure 32: North America Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028
Figure 33: North America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028
Figure 34: North America Vitamin Deficiency Treatment Market Value Share Analysis, by Country, 2019 and 2028
Figure 35: North America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country, 2020–2028
Figure 36: Europe Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028
Figure 37: Europe Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028
Figure 38: Europe Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028
Figure 39: Europe Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028
Figure 40: Europe Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028
Figure 41: Europe Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028
Figure 42: Europe Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028
Figure 43: Europe Vitamin Deficiency Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2028
Figure 44: Europe Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure 45: Asia Pacific Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028
Figure 46: Asia Pacific Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028
Figure 47: Asia Pacific Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028
Figure 48: Asia Pacific Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028
Figure 49: Asia Pacific Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028
Figure 50: Asia Pacific Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028
Figure 51: Asia Pacific Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028
Figure 52: Asia Pacific Vitamin Deficiency Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2028
Figure 53: Asia Pacific Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure 54: Latin America Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028
Figure 55: Latin America Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028
Figure 56: Latin America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028
Figure 57: Latin America Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028
Figure 58: Latin America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028
Figure 59: Latin America Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028
Figure 60: Latin America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028
Figure 61: Latin America Vitamin Deficiency Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2028
Figure 62: Latin America Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure 63: Middle East & Africa Vitamin Deficiency Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2028
Figure 64: Middle East & Africa Vitamin Deficiency Treatment Market Value Share, by Product Type, 2019 and 2028
Figure 65: Middle East & Africa Vitamin Deficiency Treatment Market Attractiveness Analysis, by Product Type, 2020–2028
Figure 66: Middle East & Africa Vitamin Deficiency Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2028
Figure 67: Middle East & Africa Vitamin Deficiency Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2028
Figure 68: Middle East & Africa Vitamin Deficiency Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2028
Figure 69: Middle East & Africa Vitamin Deficiency Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2028
Figure 70: Middle East & Africa Vitamin Deficiency Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2028
Figure 71: Middle East & Africa Vitamin Deficiency Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure 72: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018
Figure 75: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018
Figure 76: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 78: Pfizer, Inc. Breakdown of Net Sales, by Region (%), 2018
Figure 79: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 80: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018
Figure 81: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 82: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 83: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 84: Novartis AG Breakdown of Net Sales (%), by Country, 2018
Figure 85: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 86: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018
Figure 87: Cipla, Inc., Revenue (US$ Mn), 2015–2018
Figure 88: Cipla, Inc., Breakdown of Net Sales (%), Therapy-wise, 2018
Figure 90: Cipla, Inc., Breakdown of Net Sales (%), by Region, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Vitamin Deficiency Treatment Market
